Ronen Luzon - 04 Jun 2025 Form 4 Insider Report for My Size, Inc. (MYSZ)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: MYSZ
Reported as of: 04 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jun 2025, 16:10:24 UTC
Prior SEC filing: 02 Jan 2025
Next SEC filing: 21 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Ronen Luzon

Key filing fact

Ronen Luzon filed Form 4 for My Size, Inc. (MYSZ) on 06 Jun 2025.

Key facts

This page summarizes Ronen Luzon's Form 4 filing for My Size, Inc. (MYSZ).
4 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 06 Jun 2025, 16:10.

Change

Previous filing in this sequence was filed on 02 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001686315 Primary reporting owner

Luzon Ronen

Relationship: Chief Executive Officer, Director
Address: C/O MY SIZE INC., HANEGEV 4, POB 1026, AIRPORT CITY, ISRAEL
Signature: /s/ Ronen Luzon
Signature date: 06 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MYSZ transaction Derivative

Option to purchase Common Stock (right to buy)

Disposed to Issuer

Transaction value
Shares: -800
Change %: -100%
Price
Shares after: 0
Date: 04 Jun 2025
Ownership: Direct
Underlying class: Common Stock, $.001 par value per share
Underlying amount: 800
Exercise price: $8.72
Footnotes: F1, F2

MYSZ transaction Derivative

Option to purchase Common Stock (right to buy)

Award

Transaction value
Shares: +800
Change %
Price
Shares after: 800
Date: 04 Jun 2025
Ownership: Direct
Underlying class: Common Stock, $.001 par value per share
Underlying amount: 800
Exercise price: $1.28
Footnotes: F1, F2

MYSZ transaction Derivative

Option to purchase Common Stock (right to buy)

Disposed to Issuer

Transaction value
Shares: -650
Change %: -100%
Price
Shares after: 0
Date: 04 Jun 2025
Ownership: see footnote
Underlying class: Common Stock, $.001 par value per share
Underlying amount: 650
Exercise price: $8.72
Footnotes: F1, F2, F3

MYSZ transaction Derivative

Option to purchase Common Stock (right to buy)

Award

Transaction value
Shares: +650
Change %
Price
Shares after: 650
Date: 04 Jun 2025
Ownership: see footnote
Underlying class: Common Stock, $.001 par value per share
Underlying amount: 650
Exercise price: $1.28
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Footnote F2

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

Footnote F3

Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo).

SEC remarks

On December 8, 2022, the Company implemented a 1-for-25 reverse stock split (the "2022 Reverse Stock Split") of the Company's common stock, and on April 23, 2024, the Company implemented a 1-for-8 reverse stock split (the "2024 Reverse Stock Split") of the Company's common stock. All amounts have been adjusted to give effect to the 2022 Reverse Stock Split and the 2024 Reverse Stock Split.